BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25862795)

  • 1. Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E.
    Semplicini C; Vissing J; Dahlqvist JR; Stojkovic T; Bello L; Witting N; Duno M; Leturcq F; Bertolin C; D'Ambrosio P; Eymard B; Angelini C; Politano L; Laforêt P; Pegoraro E
    Neurology; 2015 Apr; 84(17):1772-81. PubMed ID: 25862795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy.
    Alonso-Pérez J; González-Quereda L; Bruno C; Panicucci C; Alavi A; Nafissi S; Nilipour Y; Zanoteli E; Isihi LMA; Melegh B; Hadzsiev K; Muelas N; Vílchez JJ; Dourado ME; Kadem N; Kutluk G; Umair M; Younus M; Pegorano E; Bello L; Crawford TO; Suárez-Calvet X; Töpf A; Guglieri M; Marini-Bettolo C; Gallano P; Straub V; Díaz-Manera J
    Brain; 2022 Apr; 145(2):596-606. PubMed ID: 34515763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
    Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
    Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic AAV-Mediated β-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice.
    Pozsgai ER; Griffin DA; Heller KN; Mendell JR; Rodino-Klapac LR
    Mol Ther; 2017 Apr; 25(4):855-869. PubMed ID: 28284983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients.
    Xie Z; Hou Y; Yu M; Liu Y; Fan Y; Zhang W; Wang Z; Xiong H; Yuan Y
    Orphanet J Rare Dis; 2019 Feb; 14(1):43. PubMed ID: 30764848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an intragenic deletion in the SGCB gene through a re-evaluation of negative next generation sequencing results.
    Giugliano T; Fanin M; Savarese M; Piluso G; Angelini C; Nigro V
    Neuromuscul Disord; 2016 Jun; 26(6):367-9. PubMed ID: 27108072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice.
    Pozsgai ER; Griffin DA; Heller KN; Mendell JR; Rodino-Klapac LR
    Gene Ther; 2016 Jan; 23(1):57-66. PubMed ID: 26214262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in alpha sarcoglycan gene in an Iranian family with limb girdle muscular dystrophy 2D.
    Mojbafan M; Nilipour Y; Tonekaboni SH; Tavakkoly-Bazzaz J; Zeinali S
    Neurol Res; 2016 Mar; 38(3):220-3. PubMed ID: 27093116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new mutation of the SCGA gene is the cause of a late onset mild phenotype limb girdle muscular dystrophy type 2D with axial involvement.
    Gonzalez-Quereda L; Gallardo E; Töpf A; Alonso-Jimenez A; Straub V; Rodriguez MJ; Lleixa C; Illa I; Gallano P; Diaz-Manera J
    Neuromuscul Disord; 2018 Aug; 28(8):633-638. PubMed ID: 30007747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene.
    Diniz G; Tosun Yildirim H; Akinci G; Hazan F; Ozturk A; Yararbas K; Tukun A
    Pediatr Neurol; 2014 Jun; 50(6):640-7. PubMed ID: 24742800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, genetic profile and disease progression of sarcoglycanopathies in a large cohort from India: high prevalence of SGCB c.544A > C.
    Bardhan M; Anjanappa RM; Polavarapu K; Preethish-Kumar V; Vengalil S; Nashi S; Sanga S; Padmanabh H; Valasani RK; Nishadham V; Keerthipriya M; Geetha TS; Ramprasad V; Arunachal G; Thomas PT; Acharya M; Nalini A
    Neurogenetics; 2022 Jul; 23(3):187-202. PubMed ID: 35416532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very late-onset limb-girdle muscular dystrophy type 2D: A milder form with a normal muscle biopsy.
    Oliveira Santos M; Coelho P; Roque R; Conceição I
    J Clin Neurosci; 2020 Feb; 72():471-473. PubMed ID: 31836381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and immunohistochemical characterization of sarcoglycanopathies.
    Ferreira AF; Carvalho MS; Resende MB; Wakamatsu A; Reed UC; Marie SK
    Clinics (Sao Paulo); 2011; 66(10):1713-9. PubMed ID: 22012042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy.
    Alonso-Pérez J; González-Quereda L; Bello L; Guglieri M; Straub V; Gallano P; Semplicini C; Pegoraro E; Zangaro V; Nascimento A; Ortez C; Comi GP; Dam LT; De Visser M; van der Kooi AJ; Garrido C; Santos M; Schara U; Gangfuß A; Løkken N; Storgaard JH; Vissing J; Schoser B; Dekomien G; Udd B; Palmio J; D'Amico A; Politano L; Nigro V; Bruno C; Panicucci C; Sarkozy A; Abdel-Mannan O; Alonso-Jimenez A; Claeys KG; Gomez-Andrés D; Munell F; Costa-Comellas L; Haberlová J; Rohlenová M; Elke V; De Bleecker JL; Dominguez-González C; Tasca G; Weiss C; Deconinck N; Fernández-Torrón R; López de Munain A; Camacho-Salas A; Melegh B; Hadzsiev K; Leonardis L; Koritnik B; Garibaldi M; de Leon-Hernández JC; Malfatti E; Fraga-Bau A; Richard I; Illa I; Díaz-Manera J
    Brain; 2020 Sep; 143(9):2696-2708. PubMed ID: 32875335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-sarcoglycan gene mutations in Turkey.
    Balci B; Wilichowski E; Haliloğlu G; Talim B; Aurino S; Kremer E; Ebinger F; Senbil N; Anlar B; Kale G; Nigro V; Topaloğlu H; Bonnemann C; Dinçer P
    Acta Myol; 2004 Dec; 23(3):154-8. PubMed ID: 15938573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first case of primary alpha-sarcoglycanopathy identified in Albania, in two siblings with homozygous alpha-sarcoglycan mutation.
    Babameto-Laku A; Tabaku M; Tashko V; Cikuli M; Mokini V
    Genet Couns; 2011; 22(4):377-83. PubMed ID: 22303798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-sarcoglycanopathy (LGMD 2E) in a Spanish family.
    Rivas E; Teijeira S; dos Santos MR; Porrit I; Leturcq F; Fernandez JM; Navarro C
    Acta Myol; 2004 Dec; 23(3):159-62. PubMed ID: 15938574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced therapeutic approaches in sarcoglycanopathies.
    Scano M; Benetollo A; Dalla Barba F; Sandonà D
    Curr Opin Pharmacol; 2024 Jun; 76():102459. PubMed ID: 38713975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare form of limb girdle muscular dystrophy (type 2E) seen in an Iranian family detected by autozygosity mapping.
    Mojbafan M; Nilipour Y; Tonekaboni SH; Bagheri SD; Bagherian H; Sharifi Z; Zeinali Z; Tavakkoly-Bazzaz J; Zeinali S
    J Neurogenet; 2016 Mar; 30(1):1-4. PubMed ID: 27276190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlations in alpha-sarcoglycanopathy: a systematic review.
    Carson L; Merrick D
    Ir J Med Sci; 2022 Dec; 191(6):2743-2750. PubMed ID: 35040091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.